As a generally held principle, mere investment or ownership interest in a company does not expose the investor to liability for acts undertaken by the company. However, that principle is being called into question in the context of private equity firms investing in healthcare companies. In two recent cases, healthcare companies along with their sole or majority private equity firm owners settled False Claims Act (“FCA”) cases. These cases illustrate the risk that private equity investors in the healthcare space may face under the FCA, particularly to the extent that they actively manage their portfolio companies.
Trending
- Patients now shop for doctors like consumers, and the bar just got higher (Medical Economics)
- AI in GI cancer care: From recognition to clinical value (ESMO)
- Could the Gut Microbiome Improve Colorectal Cancer Screening? (Technology Networks)
- DDW Expert Picks: Endoscopists’ Peripheral Gaze, Antibiotics for Cholangitis, and More (GI & Endoscopy News)
- The loopholes PE built to buy physicians are starting to crack (Becker’s Healthcare)
- Barrett Esophagus May Strike Decades Before Official Diagnosis (Medscape)
- A blood-based test for detection of advanced adenomas and colorectal cancer (DENEB): a multicentre diagnostic accuracy study (The Lancet Gastroenterology & Hepatology)
- AI can analyze your poop. Should it? (Business Insider)
